What are the challenges of allogeneic stem cell transplant in myeloma?
Re-analysis of RESONATE-2 trial of ibrutinib vs chlorambucil in CLL
Temsirolimus with BERT for the treatment of relapsed mantle cell and follicular lymphoma
Idelalisib plus bendamustine and rituximab improves the outcome of relapsed/refractory CLL
What influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?